International Journal of Colorectal Disease

, Volume 19, Issue 4, pp 325–333 | Cite as

Immunohistochemical expression of Cyclin D1, Cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features

  • Elli E. Ioachim
  • Konstantinos H. Katsanos
  • Michael C. Michael
  • Epameinondas V. Tsianos
  • Niki J. Agnantis
Original Article
First Online:
Accepted:

Abstract

Background and aims

The expression patterns of cyclins D1 and E as well as cyclin-dependent kinase inhibitors p21/waf1 and p27/kip1 and their correlation with clinical parameters and other cell cycle regulators was investigated in inflammatory bowel disease (IBD).

Patients and methods

These molecular markers were localized immunohistochemically using the monoclonal antibodies anti-cyclin D1 (DCS-6), anti-cyclin E (13A3), anti-p21 (4D10) and anti-p27 (1B4) in 70 patients with IBD, 30 patients with colorectal cancer and eight healthy subjects. Data were analyzed statistically using the software program.

Results

Cyclin D1 expression was higher in both UC and CD compared with the healthy control group. In addition, CD cyclin D1 expression was higher compared with UC cases and colorectal carcinomas. Cyclin D1 expression was correlated with disease activity and cell proliferation in UC cases. A positive relationship of cyclin D1 with p27/kip1 in both UC and CD was detected. Cyclin E expression was higher in UC, CD and carcinomas compared with healthy control group and its expression correlated with proliferative activity in both UC and CD cases. p21/waf1 expression was higher in IBD cases compared with that of the control group, while a decreased p21/waf1 expression in the group of carcinomas was noted. This expression was correlated with disease activity in UC and the proliferative activity in both UC and CD. The expression of cyclins D1 and E as well as p21/waf1 was also correlated with the existence of dysplastic lesions. A lower p27/kip1 expression in the group of carcinomas compared with IBD cases and healthy controls was found.

Conclusions

The expression patterns of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in IBD may indicate their contribution in epithelial cell turnover and their possible implication in IBD-related dysplasia-carcinoma.

Keywords

Cyclin D1 Cyclin E Inflammatory bowel disease p21/waf1 p27/kip1 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

We offer our thanks to Mrs. A. Christodoulou for her excellent technical assistance.

References

  1. 1.
    Beauchamp RD, Sheng HM, Shao JY, Thompson EA, Ko TC (1996) Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1. Ann Surg 223:620–628CrossRefPubMedGoogle Scholar
  2. 2.
    Resnitzky D, Reed SI (1995) Different roles for cyclin D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 15:3463–3469PubMedGoogle Scholar
  3. 3.
    Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512PubMedGoogle Scholar
  4. 4.
    Sgambato A, Ratto C, Faraglia B, Merico M, Ardito R, Schinzari G, Romano G, Cittadini AR (1999) Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. Mol Carcinog 26:172–179CrossRefPubMedGoogle Scholar
  5. 5.
    Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, Okayasu I (1999) Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Mod Pathol 12:604–611PubMedGoogle Scholar
  6. 6.
    Walsh S, Murphy M, Silverman M, Odze R, Antonioli D, Goldman H, Loda M (1999) p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis. Am J Pathol 155:1511–1518PubMedGoogle Scholar
  7. 7.
    Tsianos EV, Massalas C, Merkouropoulos M, Dalekos GN, Logan RF (1994) Incidence of inflammatory bowel disease in northwest Greece: rarity of Crohn’s disease in an area where ulcerative colitis is common. Gut 35:369–372PubMedGoogle Scholar
  8. 8.
    Tablot IC, Price AB (1987) Biopsy pathology in colorectal disease. Chapman and Hall, pp 117Google Scholar
  9. 9.
    Riddell RH (1995) Grading of dysplasia. Eur J Cancer 31:1169–1170CrossRefGoogle Scholar
  10. 10.
    Bukholm IK, Nesland JM (2000) Protein expression of p53, p21(WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436:224–228CrossRefGoogle Scholar
  11. 11.
    Palmqvist R, Stenling R, Oberg A, Landberg G (1999) Prognostic significance of p27(KIP1) expression in colorectal cancer: a clinico-pathological characterization. J Pathol 188:18–23CrossRefPubMedGoogle Scholar
  12. 12.
    Wong NACS, Harrison DJ (2001) Colorectal neoplasia in ulcerative colitis-recent advances. Histopathology 39:221–234CrossRefPubMedGoogle Scholar
  13. 13.
    Wong NACS, Mayer NJ, Anderson C, McKenzie HC, Morris RG, Diebold J, Mayr D, Brock IW, Royds JA, Gilmour HM and Harrison DJ (2003) Cyclin D1 and p21 WAF1/CIP1 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. Hum Pathol 34:580–588CrossRefPubMedGoogle Scholar
  14. 14.
    Kornmann M, Ishiwata T, Arber N, Beger HG, Korc M (1998) Increased cyclin D1 expression in chronic pancreatitis. Pancreas 17:158–162PubMedGoogle Scholar
  15. 15.
    Sutter T, Doi S, Carnevale KA, Arber N, Weinstein IB (1997) Expression of cyclins D1 and E in human colon adenocarcinomas. J Med 28:285–309PubMedGoogle Scholar
  16. 16.
    Wang A, Yoshimi N, Suzui M, Yamanuchi A, Tarao M, Mori H (1996) Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J Cancer Res Clin Oncol 122:122–126PubMedGoogle Scholar
  17. 17.
    Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110:669–674PubMedGoogle Scholar
  18. 18.
    Franklin WR, McDonald GB, Stein HO, Gatter KV, Jewell DP, Clarke LC and Mason DY (1985) Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol 16:1129–1132PubMedGoogle Scholar
  19. 19.
    Niffsinger A, Unger B, Fenoglio CM (1998) Increased cell proliferation characterized Crohn’s disease. Mod Pathol 11:1198–1203PubMedGoogle Scholar
  20. 20.
    Sjoqvist U, Ost A, Lofberg R (1999) Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis 14:107–113CrossRefPubMedGoogle Scholar
  21. 21.
    Wong NACS, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ (2000) Immunohistochemical assessment of Ki-67 and p53 expression assist the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 37:108–114CrossRefGoogle Scholar
  22. 22.
    Sutter T, Dansranjavin T, Lubinski J, Debniak T, Giannakudis J, Hoang-Vu C, Dralle H (2002) Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma. Int J Colorectal Dis 17: 374–380CrossRefPubMedGoogle Scholar
  23. 23.
    Noffsinger AE, Belli JM, Miller MA, Fenoglio-Preiser CM (2001) A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene. Histopathology 39:482–492CrossRefPubMedGoogle Scholar
  24. 24.
    Doglioni C, Pelosio P, Laurino L, Macri E, Meggiolaro E, Favretti F, Barbareschi M (1996) p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocaqrcinomas of the colon: its relationship with differentiation. J Pathol 179:248–253CrossRefPubMedGoogle Scholar
  25. 25.
    Girlando S, Slomp P, Caffo O, Ammichetti M, Togni R, Dvornic G, Tomio L, Galligioni E, Dalla Palma P, Barbareschi M (1999) p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinico-pathological correlations. Virchows Arch 453:559–565CrossRefGoogle Scholar
  26. 26.
    Yasui W, Akama Y, Yokozaki H, Semba S, Kudo Y, Shimamoto F, Tahara E (1997) Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathol Int 47:470–477PubMedGoogle Scholar
  27. 27.
    Uesugi H, Mitomi H, Sada M, Takahashi H, Kobayashi K, Igarashi M, Katsumata T, Ihara A, Ohtani Y, Ikeda S, Okayasu I (1999) A case of adenocarcinoma of their small intestine in a Japanese patient with Crohn’s disease: a report with immunohistochemical and oncogenic analyses. Scand J Gastroenterol 34:1162–1167CrossRefPubMedGoogle Scholar
  28. 28.
    Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M (1998) Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 153:681–687PubMedGoogle Scholar
  29. 29.
    Palmqvist R, Stenling R, Oberg A, Landberg G (1999) Prognostic significance of p27(KIP1) expression in colorectal cancer: a clinicopathological characterization. J Pathol 188:18–23CrossRefPubMedGoogle Scholar
  30. 30.
    Tenjo T, Toyoda M, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Ohtani M, Nohara T, Kawasaki HY, Tanigawa N (2000) Prognostic significance of p27 kip1 protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology 58:45–51CrossRefPubMedGoogle Scholar
  31. 31.
    Zhang H, Sun XF (2001) Loss of p27 expression predicts poor prognosis in patients with Dukes’ B stage or proximal colorectal cancer. Int J Oncol 19:49–52PubMedGoogle Scholar
  32. 32.
    Arber N, Hibshoosh H, Yasui W, Neugut AI, Hibshoosh A, Yao Y, Sgambato A, Yamamoto H, Shapira I, Rosenman D, Fabian I, Weinstein IB, Tahara E, Holt PR (1999) Abnormalities in the expression of cell cycle related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 8:1101–1105PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Elli E. Ioachim
    • 1
  • Konstantinos H. Katsanos
    • 2
  • Michael C. Michael
    • 1
  • Epameinondas V. Tsianos
    • 2
  • Niki J. Agnantis
    • 1
  1. 1.Department Pathology (Hepato-Gastroenterology Unit), Medical SchoolUniversity of IoanninaIoanninaGreece
  2. 2.Department of Internal Medicine (Hepato-Gastroenterology Unit), Medical SchoolUniversity of IoanninaIoanninaGreece

Personalised recommendations